Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Press Releases

Fish Named to NLJ’s “2014 Intellectual Property Hot List” for Third Straight Year

June 13, 2014

Press Releases

Fish Named to NLJ’s “2014 Intellectual Property Hot List” for Third Straight Year

June 13, 2014

Back to News Listing

Boston, MA, June 13, 2014 – Fish & Richardson has been named to The National Law Journal’s (NLJ) “2014 Intellectual Property Hot List” as one of 20 firms that “have become leaders on the latest trends in intellectual property law.” This is the third year that Fish has been named to the NLJ “IP Hot List,” which the publication started in 2012.

“We are honored to again be named one of the best IP firms in the country,” said Ann Cathcart Chaplin, Litigation Practice Group Leader at Fish & Richardson. “This NLJ recognition confirms what our clients and opponents already know – Fish is a force to be reckoned with when it comes to winning the most complex, high stakes intellectual property cases in the country.”

The NLJ noted that Fish “made several client wins official last year through appellate rulings that put the stamp of approval on the firm’s trial court victories.” In Fresenius USA v. Baxter International, Fish convinced the U.S. Court of Appeals for the Federal Circuit to throw out Baxter’s infringement case on a novel theory. The court said Baxter’s case had been nullified when Fish persuaded the U.S. Patent and Trademark Office to invalidate Baxter’s patent on hemodialysis machine technology. The U.S. Supreme Court denied Baxter’s petition for certiorari.

Fish’s patent, trial and appellate practices worked together to seamlessly handle the case from trial through appeal, while initiating parallel PTO proceedings.

According to Fish client, Jay Morris, Chief Intellectual Property Counsel for Fresenius Medical Care North America, “Fish is unusual in having absolutely top-quality litigators in the very same office as top-quality patent prosecutors.”

The NLJ also highlighted that “Fish racked up two Federal Court wins that protected billions of dollars in Allergan Inc.’s glaucoma product sales” in 2013, and also “helped 75 defendants defeat a nonpracticing entity… before the Federal Circuit in a case testing (the plaintiff’s) website technology patent.”

Stay current with Fish Sign up for our Newsletter